In Year Made Unusual By COVID-19, Still More Unusual Consumer Health Claims Surface In US
Executive Summary
An ultraviolet lamp marketer was dinged by industry self-regulation for COVID-19 claims; the largest US natural food grocery chain had one too many undeclared allergens for the FDA's liking; and warnings note cannabidiol-containing eye drops, nasal sprays and inhalers promoted with drug claims.
You may also be interested in...
Requiring Infant Formula, Medical Food Shortage Updates Included In US FDA Budget Request
FDA’s justification report published with Biden administration’s FY2022 federal budget request includes $1.194bn for agency’s food programs, which include its oversight of supplement industry, up from $1.11bn in FY2021 appropriation.
Ginger, Mushroom, Aloe Supplements Get US FDA Warnings For Disease Claims
Three firms were warned after FDA inspectors reviewed their websites or social media posts. No facility inspections nor warnings about GMP problems were noted in the letters.
Like Kentucky’s Senior Senator, Paul Hoists Legislative Flag For US Hemp Industry Growth
Sen. Paul’s HEMP Act would raise from 0.3% to 1% the level of THC by dry weight in hemp under the 2018 farm bill. The bill also would require testing for THC levels in final products containing cannabinoids and other hemp-derived ingredients rather than within 15 days of harvest.